(2-Chloro-5-isobutoxyphenyl)boronic acid, 95.0%, 10g

[2-(4-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-2-yl)ethyl]amine dihydrochloride, 95.0%, 250mg

Espátulas dobles, una hoja de espátula redondeada, 240 mm, 12 mm, 1 Pieza

(4-Methyl-4H-[1,2,4]triazol-3-yl)methanol, 95.0%, 250mg

Bi polvo 99,9% -325 malla 100 g

tert-Butyl N-[(1S)-1-[Methoxy(methyl)carbamoyl]-2-phenylethyl]carbamate, 98%, 5g

1,1,3,3,5,5, Hexamethyl diethoxy trisiloxane, 97%, 25g

3-ACETYL-1H-QUINOLIN-2-ONE, 95.0%, 1g

Methyl 6-chloro-5-nitropicolinate, 95%, 10g

Ethyl 2-(5-bromopyrimidin-4-yl)acetate, 95.0%, 5g

Trimethylolpropane Tris(3-mercaptopropionate)>85.0%(GC)500g

4-Amino-6-chloro-5-fluoronicotinamide, 98%, 500mg

H-Ile-CMK�HCl, 95.0%, 250mg